BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26581399)

  • 1. Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo study.
    Yoon JS; Hwang DW; Kim ES; Kim JS; Kim S; Chung HJ; Lee SK; Yi JH; Uhm J; Won YW; Park BB; Choi JH; Lee YY
    Invest New Drugs; 2016 Feb; 34(1):1-14. PubMed ID: 26581399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells.
    Liu Y; Shin DY; Oh S; Kim S; Koh Y; Kim I
    Oncol Rep; 2017 Jul; 38(1):481-487. PubMed ID: 28586017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities.
    Lee EJ; Sung JY; Koo KH; Park JB; Kim DH; Shim J; Lee CH; Park J; Kim YN
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumoral effect of arsenic compound, sodium metaarsenite (KML001), on multiple myeloma cells.
    Kim SJ; Kim ES; Kim S; Uhm J; Won YW; Park BB; Choi JH; Lee YY
    Int J Oncol; 2017 Dec; 51(6):1739-1746. PubMed ID: 29039521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway.
    You D; Kim Y; Jang MJ; Lee C; Jeong IG; Cho YM; Hwang JJ; Hong JH; Ahn H; Kim CS
    PLoS One; 2015; 10(9):e0137589. PubMed ID: 26352139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-leukemic effect of sodium metaarsenite (KML001) in acute myeloid leukemia with breaking-down the resistance of cytosine arabinoside.
    Yoon JS; Kim ES; Park BB; Choi JH; Won YW; Kim S; Lee YY
    Int J Oncol; 2015 May; 46(5):1953-62. PubMed ID: 25695330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
    Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
    Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells.
    Zebboudj A; Maroui MA; Dutrieux J; Touil-Boukoffa C; Bourouba M; Chelbi-Alix MK; Nisole S
    Biochimie; 2014 Dec; 107 Pt B():247-56. PubMed ID: 25241256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KML001 displays vascular disrupting properties and irinotecan combined antitumor activities in a murine tumor model.
    Moon CH; Lee SJ; Lee HY; Lee JC; Cha H; Cho WJ; Park JW; Park HJ; Seo J; Lee YH; Song HT; Min YJ
    PLoS One; 2013; 8(1):e53900. PubMed ID: 23326531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KML001 inhibits cell proliferation and invasion in pancreatic cancer cells through suppression of NF-κB and VEGF-C.
    Yang MH; Kim HT; Lee KT; Yang S; Lee JK; Lee KH; Rhee JC
    Anticancer Res; 2014 Jul; 34(7):3469-74. PubMed ID: 24982355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of androgen receptors by NaAsO
    Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS
    Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
    Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
    Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study.
    Jo JH; Kang H; Lee HS; Chung MJ; Park JY; Bang S; Park SW; Song SY
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):62-66. PubMed ID: 30612929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis.
    Woo SR; Ham Y; Kang W; Yang H; Kim S; Jin J; Joo KM; Nam DH
    Biomed Res Int; 2014; 2014():747415. PubMed ID: 25295271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular Dysfunctions.
    Cao D; Zhao J; Nguyan LN; Nguyen LNT; Khanal S; Dang X; Schank M; Chand Thakuri BK; Wu XY; Morrison ZD; El Gazzar M; Zou Y; Ning S; Wang L; Moorman JP; Yao ZQ
    Front Immunol; 2019; 10():1152. PubMed ID: 31191531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of cellular glutathione homeostasis for trivalent inorganic arsenite-induced oxidative damage in human bronchial epithelial cells.
    Jiang X; Chen C; Liu Y; Zhang P; Zhang Z
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Aug; 770():35-45. PubMed ID: 25344162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
    Jazirehi AR; Bonavida B
    Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenite-induced apoptosis is prevented by selenite in A375 cell line.
    Wang ZF; Guo X
    Biol Trace Elem Res; 2011 Apr; 140(1):7-17. PubMed ID: 20390378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide rewires mantle cell lymphoma response to bortezomib.
    Zhao LL; Liu YF; Peng LJ; Fei AM; Cui W; Miao SC; Hermine O; Gressin R; Khochbin S; Chen SJ; Wang J; Mi JQ
    Cancer Med; 2015 Nov; 4(11):1754-66. PubMed ID: 26310857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds.
    Glienke W; Chow KU; Bauer N; Bergmann L
    Leuk Lymphoma; 2006 Aug; 47(8):1629-38. PubMed ID: 16966277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.